Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-23-009354

Options or other derivatives

  • Chief Scientific Officer acquired 142,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-01-30 Grant or award : show line 1 in the form Stock Options (option to buy) +105,000 105,000 D
2023-01-30 Grant or award : show line 2 in the form Restricted Stock Units +37,100 37,100 D
Loading xslF345X03/tm235142-3_4seq1.xml…